Sirio Pharma Co., Ltd. (SHE:300791)
17.30
-0.06 (-0.35%)
Nov 17, 2026, 12:04 PM CST
Sirio Pharma Revenue
Sirio Pharma had revenue of 1.01B CNY in the quarter ending September 30, 2026, a decrease of -18.94%. This brings the company's total for the last twelve months to 4.04B, down -9.36% year-over-year. In the year 2025, Sirio Pharma had annual revenue of 4.26B with 1.23% growth. That makes Sirio Pharma the 10,199th largest company in the world by revenue and 1,658th in China.
Revenue (ttm)
4.04B
Revenue Growth
-9.36%
P/S Ratio
1.32
Revenue / Employee
1.45M
Employees
2,776
Market Cap
5.31B
Revenue by Geography
- China 1.71B 40.2%
- Americas 1.55B 36.4%
- Europe 755.30M 17.7%
- Other Areas 241.70M 5.7%
Fiscal year ended Dec 31, 2025 See the full Sirio Pharma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.26B | 51.84M | 1.23% |
| Dec 31, 2024 | 4.21B | 629.04M | 17.56% |
| Dec 31, 2023 | 3.58B | 1.07B | 42.87% |
| Jan 1, 2023 | 2.51B | 138.31M | 5.84% |
| Dec 31, 2021 | 2.37B | 302.13M | 14.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Bright Meat Group | 23.03B |
| Tangrenshen Group | 22.23B |
| Guangdong Yuehai Feeds Group | 8.03B |
| SDIC Zhonglu Fruit Juice | 8.00B |
| V V Food & Beverage Co.,Ltd | 3.54B |
| Shanghai Bolex Food Technology | 3.25B |
| XIANGPIAOPIAO Food Co.,Ltd | 3.10B |
| Namchow Food Group (Shanghai) | 2.97B |